Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Cancer still eludes treatment, and tumors frequently evolve resistance mechanisms to get around medications. By making cancer ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common ...

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

Scientists studying an aggressive cancer that affects thousands of dogs annually have uncovered a genetic signature that ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

A major limitation of this type of CAR T cell therapy, called autologous therapy, is that the cells are taken from the ...

In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...